These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37582935)

  • 1. Author Correction: Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave.
    Sun CLF; Jaffe E; Levi R
    Sci Rep; 2023 Aug; 13(1):13276. PubMed ID: 37582935
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave.
    Sun CLF; Jaffe E; Levi R
    Sci Rep; 2022 Apr; 12(1):6978. PubMed ID: 35484304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Rollout and Initial Uptake of a Booster COVID-19 Vaccine Among Israel Defense Forces Soldiers.
    Talmy T; Nitzan I
    J Prev (2022); 2023 Feb; 44(1):1-14. PubMed ID: 35972594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Covid-19 vaccination rollout: a commentary from England.
    Sim F
    Isr J Health Policy Res; 2021 Feb; 10(1):18. PubMed ID: 33637133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six Pivotal Lessons Learned in South Korea for Whole-of-Government Approach to Successful COVID-19 Vaccine Rollout in Planetary Health.
    Hong SA
    OMICS; 2022 Oct; 26(10):567-579. PubMed ID: 36112347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries.
    Khalifa BA; Abbey EJ; Ayeh SK; Yusuf HE; D Nudotor R; Osuji N; Khan S; Nosakhare E; Oduwole MO; Salia EL; Lasisi O; Karakousis PC
    Int J Infect Dis; 2021 Dec; 113():7-11. PubMed ID: 34547494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Care Interventions to Address COVID-19 Vaccine Hesitancy Among Israel Defense Forces Soldiers.
    Talmy T; Cohen B; Nitzan I; Ben Michael Y
    J Community Health; 2021 Dec; 46(6):1155-1160. PubMed ID: 33988777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rollout of the COVID-19 vaccination: what can Canada learn from Israel?
    Marchildon GP
    Isr J Health Policy Res; 2021 Feb; 10(1):12. PubMed ID: 33596962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers.
    Gilboa M; Tal I; Levin EG; Segal S; Belkin A; Zilberman-Daniels T; Biber A; Rubin C; Rahav G; Regev-Yochay G
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1433-1438. PubMed ID: 34551833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccination Compliance and Associated Factors among Medical Students during an Early Phase of Vaccination Rollout-A Survey from Israel.
    Katz M; Azrad M; Glikman D; Peretz A
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Barda N; Dagan N; Cohen C; Hernán MA; Lipsitch M; Kohane IS; Reis BY; Balicer RD
    Lancet; 2021 Dec; 398(10316):2093-2100. PubMed ID: 34756184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many lives do COVID vaccines save? Evidence from Israel.
    Arbel R; Moore CM; Sergienko R; Pliskin J
    Am J Infect Control; 2022 Mar; 50(3):258-261. PubMed ID: 34971714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk communication on vaccines during the COVID19 pandemic: is there room for small size or private initiatives? An Israeli experience.
    Fermont IR; Livneh A; Benhamou M
    Ther Adv Drug Saf; 2022; 13():20420986221112189. PubMed ID: 35958047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study.
    Yamin D; Yechezkel M; Arbel R; Beckenstein T; Sergienko R; Duskin-Bitan H; Yaron S; Peretz A; Netzer D; Shmueli E
    Lancet Infect Dis; 2023 Oct; 23(10):1130-1142. PubMed ID: 37352878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a nationwide booster vaccine rollout in Israel on SARS-CoV-2 infection and severe illness in young adults.
    Bomze D; Sprecher E; Gamzu R
    Travel Med Infect Dis; 2021; 44():102195. PubMed ID: 34737149
    [No Abstract]   [Full Text] [Related]  

  • 16. Pan-serotype Reduction in Progression of Streptococcus pneumoniae to Otitis Media After Rollout of Pneumococcal Conjugate Vaccines.
    Lewnard JA; Givon-Lavi N; Weinberger DM; Lipsitch M; Dagan R
    Clin Infect Dis; 2017 Nov; 65(11):1853-1861. PubMed ID: 29020218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia's Vaccine Rollout Slower than That of Other Nations?
    Mikule E; Reissaar T; Villers J; Takoupo Penka AS; Temerev A; Rozanova L
    Epidemiologia (Basel); 2021 Aug; 2(3):360-376. PubMed ID: 36417231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohort study.
    Collett G; Godec T; Gupta AK;
    Hum Vaccin Immunother; 2023 Dec; 19(1):2188823. PubMed ID: 36977613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 vaccine rollout and labor market recovery in the U.S: a note.
    Ogundari K
    SN Bus Econ; 2022; 2(7):75. PubMed ID: 35789709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publisher Correction to: The rollout of the COVID-19 vaccination: what can Canada learn from Israel?
    Marchildon GP
    Isr J Health Policy Res; 2021 Feb; 10(1):20. PubMed ID: 33637101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.